Glucagon-Like Peptides

In this video, David Nathan, MD, discusses the various treatment options for patients with diabetes.

Sodium-glucose cotransporter-2 inhibitors showed similar hepatic effectiveness to glucagon-like peptide-1 receptor agonists, especially among women and younger patients, in metabolic dysfunction-associated steatotic liver disease.

Adults with obstructive sleep apnea treated with CPAP for 24 weeks had improved vascular inflammation and lower unstable plaque volume, according to results published in Annals of the American Thoracic Society.

Among patients with diabetes undergoing emergency surgery, the risk for respiratory complications afterward was not heightened with glucagon-like peptide-1 receptor agonist use, according to a research letter published in JAMA.

Data has indicated thiazolidinedione pioglitazone and GLP-1 receptor agonists improve beta-cell function in patients with diabetes, prompting a meeting presenter to suggest both drugs be used as first-line therapies for the disease.